- Reuters
Save time and jump to the most important pieces.
10-Q - SCWorx Corp. (0001674227) (Filer)
8-K - SCWorx Corp. (0001674227) (Filer)
10-Q - SCWorx Corp. (0001674227) (Filer)
NEW YORK, N.Y., Nov. 20, 2024 (GLOBE NEWSWIRE) -- SCWorx Corp. (NASDAQ:WORX) (the "Company"), a provider of data management services to healthcare providers, announced today that it has regained compliance with The Nasdaq Stock Market's ("Nasdaq") continued listing requirements regarding periodic reporting. On April 17, May 17, and August 19, 2024, Nasdaq notified the Company that it no longer met the Nasdaq's periodic filing requirement under Listing Rule 5250(c)(1) (the "Rule"). In a letter dated October 14, 2024, Nasdaq indicated that based on the September 24, October 10, and October 11, 2024, filing of the Company's Form 10-K for the year ended December 31, 2023, and Forms 10-Q for
New York, NY, Nov. 20, 2024 (GLOBE NEWSWIRE) -- SCWorx Corp (the "Company"), on November 19th, 2024 completed an equity financing with institutional investors (the "Institutional Investors" or "Investors"). In connection with the funding, the Company sold an aggregate of 232,558 shares of common stock and warrants to purchase the same number of shares of common stock, for aggregate gross proceeds of $200,000. The Company will be registering for resale the shares of common stock and warrant shares with U.S. Securities and Exchange Commission (the "SEC"). SCWorx expects to use net proceeds from the financing for working capital and general corporate purposes to support its future growth.
NEW YORK, N.Y., Aug. 23, 2024 (GLOBE NEWSWIRE) -- On August 19, 2024, the Nasdaq Stock Market notified SCWorx Corp. (the "Company") that it has failed to satisfy a standard for continued listing, namely Nasdaq Listing Rule 5250(c)(1) (the "Rule), because the Company did not file its June 30, 2024 Quarterly Report on Form 10-Q by the due date of August 14, 2024 and because it remains delinquent in filing its Form 10-K for the period ended December 31, 2023 and its Form 10Q for the quarter ended March 31, 2024. As previously disclosed, due to the SEC's Order denying BF Borgers CPA PC ("BF Borgers") the privilege of appearing or practicing before the Commission as an accountant, on May 7
- Reuters
SC 13G - SCWorx Corp. (0001674227) (Subject)
SC 13G/A - SCWorx Corp. (0001674227) (Subject)
3 - SCWorx Corp. (0001674227) (Issuer)
3 - SCWorx Corp. (0001674227) (Issuer)
4 - SCWorx Corp. (0001674227) (Issuer)
New York, NY, Oct. 10, 2023 (GLOBE NEWSWIRE) -- SCWorx Corp. (NASDAQ:WORX) announces the successful conclusion of its 2023 Annual Meeting of Stockholders (the "Meeting"). The Meeting yielded significant positive outcomes, instilling confidence in the Company amongst investors and stakeholders with shareholders embracing the reverse stock split and showing overwhelming support for the Company. Following the Meeting, the Company's Board of Directors (the "Board") approved a final ratio of 15-for-1 for the reverse stock split (the "Split"), which was within the parameters approved by the shareholders. The Split is expected to become effective at market open on October 11, 2023, pending conf
NEW YORK, N.Y., June 01, 2021 (GLOBE NEWSWIRE) -- SCWorx Corp. (NASDAQ:WORX), a provider of data management services to healthcare providers, announced today that it has regained compliance with The Nasdaq Stock Market's ("Nasdaq") continued listing requirements regarding annual stockholder meetings and periodic reporting. In a letter dated May 25, 2021, Nasdaq indicated that SCWorx has regained compliance with its continued listing requirements for periodic reporting as a result of the filing of the Company's Annual Report on Form 10-K for the year ended December 31, 2020. In addition, the Company received a letter from Nasdaq on May 27, 2021 indicating that it has regained compliance wi
NEW YORK, NY, March 15, 2021 (GLOBE NEWSWIRE) -- SCWorx Corp. (NASDAQ: WORX), a provider of data management services to healthcare providers, announced today its Board of Directors has appointed Alton Irby to serve as a board member, effective immediately. “We are pleased to welcome Mr. Irby to the SCWorx board of directors,” said Tim Hannibal, President and COO of SCWorx. “We believe that Mr. Irby’s long experience as an investment banker and advisor to many corporate boards in both the United States and Europe will bring valuable experience to SCWorx. In particular, his 17 year tenure as a senior member of the Board of McKesson Corporation gives him valuable experience in healthcare